Calumet (CLMT) Stock Could Be 39.2% Overvalued After Oil Price Weakness

Calumet, Inc.

Calumet, Inc.

CLMT

0.00

Oil’s latest slide, following the Iran peace deal and weaker Brent and WTI prices, has fed through to Calumet (CLMT). The stock has dropped 2.7% as investors reassess energy related revenue expectations.

Despite the latest pullback, Calumet’s recent share price performance has been strong. The 90 day share price return is 16.41% and the year to date share price return is 66.96%, while the 1 year total shareholder return is 98.66%.

If you are reassessing energy exposure after this oil move, it can help to compare other opportunities using a focused stock list such as 20 top founder-led companies

So with Calumet posting a 98.66% 1 year total shareholder return and analysts’ price targets sitting above the current US$32.64 share price, is there still an opportunity here, or is the market already pricing in future growth?

Most Popular Narrative: 39.2% Overvalued

Calumet’s most followed narrative puts fair value at $23.45, comfortably below the latest $32.64 close. This makes its recent share price strength a key point for investors to interrogate.

Fair Value has moved from $22.65 to $23.45, indicating a modest upward adjustment in the estimated equity value per share. Discount Rate has shifted from 7.90% to about 7.62%, a small reduction in the rate used to discount future cash flows.

Want to see what sits behind that gap between price and fair value? The narrative leans on revenue compounding, margin repair and a punchy future earnings multiple. It is worth examining which assumptions really carry the model.

Result: Fair Value of $23.45 (OVERVALUED)

However, Calumet’s reliance on supportive regulation for renewable fuels and its substantial debt load could quickly challenge this overvaluation narrative if conditions or execution fall short.

Next Steps

Given the mixed signals around Calumet, it helps to act quickly and review both the potential upside and the concerns for yourself using the 2 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Calumet?

If Calumet has sharpened your focus on opportunities, do not stop here. Use targeted stock lists to quickly surface other candidates that may better fit your goals.

  • Target dependable income by reviewing companies in the 8 dividend fortresses that may suit a yield focused portfolio.
  • Hunt for potential value opportunities by scanning the 45 high quality undervalued stocks and comparing fundamentals against your expectations.
  • Prioritize resilience by assessing companies in the 66 resilient stocks with low risk scores that align with your tolerance for volatility.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.